Filter
715
Text search:
drug
manufacturing
Featured
Recommendations
59
New Publications
189
Language
Document type
No document type
368
Studies & Reports
132
Guidelines
119
Manuals
34
Strategic & Response Plan
34
Fact sheets
10
Situation Updates
9
Training Material
3
Resource Platforms
3
Infographics
2
Brochures
1
Countries / Regions
India
36
Kenya
31
Global
30
Nigeria
20
Ghana
20
Ethiopia
19
Uganda
19
Sierra Leone
13
Western and Central Europe
13
Nepal
12
Zambia
12
Tanzania
12
South Africa
12
Bangladesh
12
Malawi
9
Botswana
9
Liberia
8
Zimbabwe
8
Ukraine
8
Lesotho
8
Africa
8
Namibia
7
Myanmar / Burma
7
South–East Asia Region
7
Philippines
6
Rwanda
6
Latin America and the Carribbean
6
Indonesia
5
Eastern Europe
5
Eswatini/ Swaziland
4
Haiti
3
Cambodia
3
Thailand
3
East and Southern Africa
3
West and Central Africa
3
Albania
3
Tajikistan
3
Russia
3
Senegal
2
Cameroon
2
Pakistan
2
Germany
2
Mozambique
2
Sudan
2
Western Pacific Region
2
Asia
2
Laos
2
Moldova
2
Guinea
1
Congo, Democratic Republic of
1
USA
1
South Sudan
1
Syria
1
China
1
Benin
1
Brazil
1
Serbia
1
Madagascar
1
Sri Lanka
1
Middle East and North Africa
1
Eastern Europe and Central Asia
1
Solomon Islands
1
Southern Africa
1
Uzbekistan
1
Australia
1
Vietnam
1
Turkmenistan
1
Maldives
1
Mauritius
1
Authors & Publishers
Publication Years
Category
Countries
298
Clinical Guidelines
57
Pharmacy & Technologies
31
Public Health
29
Key Resources
18
Women & Child Health
13
Capacity Building
4
Toolboxes
Pharmacy
84
AMR
81
COVID-19
53
HIV
47
TB
37
Mental Health
34
Planetary Health
16
Ebola
14
Rapid Response
14
NTDs
13
NCDs
12
Global Health Education
11
Health Financing Toolbox
9
Conflict
5
Specific Hazards
5
Caregiver
4
Cholera
3
Natural Hazards
3
Polio
2
Disability
1
Refugee
1
Zika
1
Towards a Healthier Botswana
Act 851 | AN ACT to revise and consolidate the law relating to public health to
prevent disease, promote, safeguard, maintain and protect the health
of humans and animals and to provide for related matters.
Direct acting antivirals (DAAs) have revolutionized treatment for hepatitis C. Combi-
nations of DAAs can cure infection with HCV in 12 weeks, are highly effective and
have limited side-effects. Affordability of DAAs has improved significantly, but access remains lim-
i
...
Document No. : FDA/SMC/CTD/GL-CCT/2013/01
Lessons from the STEP-TB Project.
Accessed November 2017.